Consistent with our expectations, treatment with baricitinib did not alter the susceptibility of Samhd1-deficient larvae to STM infection, which showed a survival rate approximately 30% higher than that of WT larvae and similar to that of untreated Samhd1-deficient larvae (Figure 4B). Here, SAMHD1 is linked to infection.